Annual Total Liabilities
$11.74 M
-$676.30 K-5.45%
December 1, 2022
Summary
- As of February 10, 2025, DMK annual total liabilities is $11.74 million, with the most recent change of -$676.30 thousand (-5.45%) on December 1, 2022.
- During the last 3 years, DMK annual total liabilities has fallen by -$3.10 million (-20.89%).
Performance
DMK Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
$14.25 M
-$2.32 M-14.01%
September 1, 2023
Summary
- As of February 10, 2025, DMK quarterly total liabilities is $14.25 million, with the most recent change of -$2.32 million (-14.01%) on September 1, 2023.
- Over the past year, DMK quarterly total liabilities has increased by +$4.96 million (+53.38%).
Performance
DMK Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
DMK Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -5.5% | +53.4% |
3 y3 years | -20.9% | -13.7% |
5 y5 years | -1.0% | +14.9% |
DMK Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -5.4% | at low | -24.0% | -34.8% |
5 y | 5-year | -57.1% | at low | -47.9% | -34.8% |
alltime | all time | -57.1% | -97.4% | -47.9% | -100.7% |
DMK Pharmaceuticals Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | $14.25 M(-14.0%) |
Jun 2023 | - | $16.57 M(-11.6%) |
Mar 2023 | - | $18.76 M(+59.8%) |
Dec 2022 | $11.74 M(-5.4%) | $11.74 M(+26.3%) |
Sep 2022 | - | $9.29 M(-12.8%) |
Jun 2022 | - | $10.65 M(-27.3%) |
Mar 2022 | - | $14.65 M(+18.0%) |
Dec 2021 | $12.42 M(-54.6%) | $12.42 M(+17.1%) |
Sep 2021 | - | $10.61 M(-37.7%) |
Jun 2021 | - | $17.03 M(-33.1%) |
Mar 2021 | - | $25.46 M(-7.0%) |
Dec 2020 | $27.37 M(+84.4%) | $27.37 M(+65.7%) |
Sep 2020 | - | $16.52 M(-0.4%) |
Jun 2020 | - | $16.58 M(+37.5%) |
Mar 2020 | - | $12.06 M(-18.7%) |
Dec 2019 | $14.84 M(+27.2%) | $14.84 M(+18.3%) |
Sep 2019 | - | $12.54 M(-5.6%) |
Jun 2019 | - | $13.28 M(+3.1%) |
Mar 2019 | - | $12.88 M(+10.4%) |
Dec 2018 | $11.67 M(-1.6%) | $11.67 M(-5.9%) |
Sep 2018 | - | $12.40 M(-11.1%) |
Jun 2018 | - | $13.96 M(+35.0%) |
Mar 2018 | - | $10.33 M(-12.8%) |
Dec 2017 | $11.86 M(-5.2%) | $11.86 M(+15.4%) |
Sep 2017 | - | $10.28 M(+1.7%) |
Jun 2017 | - | $10.11 M(-21.1%) |
Mar 2017 | - | $12.82 M(+2.5%) |
Dec 2016 | $12.51 M(+355.1%) | $12.51 M(+4.3%) |
Sep 2016 | - | $11.99 M(-16.4%) |
Jun 2016 | - | $14.33 M(+261.8%) |
Mar 2016 | - | $3.96 M(+44.2%) |
Dec 2015 | $2.75 M(-19.0%) | $2.75 M(+23.2%) |
Sep 2015 | - | $2.23 M(+6.3%) |
Jun 2015 | - | $2.10 M(-7.7%) |
Mar 2015 | - | $2.28 M(-1.9%) |
Dec 2014 | $3.39 M(+15.7%) | - |
Sep 2014 | - | $2.32 M(+21.7%) |
Jun 2014 | - | $1.91 M(-35.0%) |
Mar 2014 | $2.93 M(-37.3%) | $2.93 M(-37.1%) |
Dec 2013 | - | $4.67 M(-44.8%) |
Sep 2013 | - | $8.46 M(-6.9%) |
Jun 2013 | - | $9.09 M(+94.2%) |
Mar 2013 | $4.68 M(+61.7%) | $4.68 M(+12.3%) |
Dec 2012 | - | $4.16 M(-28.6%) |
Sep 2012 | - | $5.83 M(-3.5%) |
Jun 2012 | - | $6.05 M(+109.1%) |
Mar 2012 | $2.89 M(-7.1%) | $2.89 M(+15.5%) |
Dec 2011 | - | $2.50 M(+4.7%) |
Sep 2011 | - | $2.39 M(+25.0%) |
Jun 2011 | - | $1.91 M(-38.6%) |
Mar 2011 | $3.11 M(-37.1%) | $3.11 M(-7.3%) |
Dec 2010 | - | $3.36 M(-33.2%) |
Sep 2010 | - | $5.03 M(-12.7%) |
Jun 2010 | - | $5.75 M(+16.3%) |
Mar 2010 | $4.95 M | $4.95 M(+24.7%) |
Dec 2009 | - | $3.97 M(+13.9%) |
Sep 2009 | - | $3.49 M(+21.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2009 | - | $2.88 M(+124.4%) |
Mar 2009 | - | $1.28 M(+23.9%) |
Dec 2008 | $1.03 M(+14.4%) | $1.03 M(+10.3%) |
Sep 2008 | - | $938.00 K(+4.3%) |
Jun 2008 | - | $899.00 K(+4.9%) |
Mar 2008 | - | $857.00 K(-5.2%) |
Dec 2007 | $904.30 K(-16.4%) | $904.30 K(+42.2%) |
Sep 2007 | - | $636.00 K(+15.2%) |
Jun 2007 | - | $552.00 K(-30.4%) |
Mar 2007 | - | $793.00 K(-26.7%) |
Dec 2006 | $1.08 M(-91.6%) | $1.08 M(-91.5%) |
Sep 2006 | - | $12.78 M(+8.6%) |
Jun 2006 | - | $11.77 M(-5.5%) |
Mar 2006 | - | $12.45 M(-3.7%) |
Dec 2005 | $12.93 M(-37.3%) | $12.93 M(+17.7%) |
Sep 2005 | - | $10.98 M(+7.7%) |
Jun 2005 | - | $10.20 M(-50.4%) |
Mar 2005 | - | $20.54 M(-0.3%) |
Dec 2004 | $20.61 M(+21.8%) | $20.61 M(+618.2%) |
Sep 2004 | - | $2.87 M(-83.1%) |
Jun 2004 | - | $16.98 M(-2.8%) |
Mar 2004 | - | $17.47 M(+3.3%) |
Dec 2003 | $16.91 M(-5.2%) | $16.91 M(+2.1%) |
Sep 2003 | - | $16.56 M(-2.0%) |
Jun 2003 | - | $16.89 M(+0.5%) |
Mar 2003 | - | $16.82 M(-5.8%) |
Dec 2002 | $17.84 M(+607.4%) | $17.84 M(+775.6%) |
Sep 2002 | - | $2.04 M(-38.6%) |
Jun 2002 | - | $3.32 M(+16.3%) |
Mar 2002 | - | $2.85 M(+13.0%) |
Dec 2001 | $2.52 M(+2.4%) | $2.52 M(+54.9%) |
Sep 2001 | - | $1.63 M(+33.1%) |
Jun 2001 | - | $1.22 M(-55.4%) |
Mar 2001 | - | $2.75 M(+11.4%) |
Dec 2000 | $2.46 M(-51.4%) | $2.46 M(-34.4%) |
Sep 2000 | - | $3.76 M(-15.7%) |
Jun 2000 | - | $4.46 M(+7.0%) |
Mar 2000 | - | $4.17 M(-17.9%) |
Dec 1999 | $5.07 M(-4.3%) | $5.07 M(+1.5%) |
Sep 1999 | - | $5.00 M(-9.1%) |
Jun 1999 | - | $5.50 M(+12.2%) |
Mar 1999 | - | $4.90 M(-7.5%) |
Dec 1998 | $5.30 M(+307.7%) | $5.30 M(+341.7%) |
Sep 1998 | - | $1.20 M(+100.0%) |
Jun 1998 | - | $600.00 K(-14.3%) |
Mar 1998 | - | $700.00 K(-46.2%) |
Dec 1997 | $1.30 M(+333.3%) | $1.30 M(+85.7%) |
Sep 1997 | - | $700.00 K(-800.0%) |
Jun 1997 | - | -$100.00 K(-150.0%) |
Mar 1997 | - | $200.00 K(-33.3%) |
Dec 1996 | $300.00 K(-25.0%) | $300.00 K(+50.0%) |
Sep 1996 | - | $200.00 K(+100.0%) |
Jun 1996 | - | $100.00 K(-50.0%) |
Mar 1996 | - | $200.00 K(-50.0%) |
Dec 1995 | $400.00 K | $400.00 K(+100.0%) |
Sep 1995 | - | $200.00 K(-91.7%) |
Jun 1995 | - | $2.40 M |
FAQ
- What is DMK Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for DMK Pharmaceuticals?
- What is DMK Pharmaceuticals annual total liabilities year-on-year change?
- What is DMK Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for DMK Pharmaceuticals?
- What is DMK Pharmaceuticals quarterly total liabilities year-on-year change?
What is DMK Pharmaceuticals annual total liabilities?
The current annual total liabilities of DMK is $11.74 M
What is the all time high annual total liabilities for DMK Pharmaceuticals?
DMK Pharmaceuticals all-time high annual total liabilities is $27.37 M
What is DMK Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, DMK annual total liabilities has changed by -$676.30 K (-5.45%)
What is DMK Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of DMK is $14.25 M
What is the all time high quarterly total liabilities for DMK Pharmaceuticals?
DMK Pharmaceuticals all-time high quarterly total liabilities is $27.37 M
What is DMK Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, DMK quarterly total liabilities has changed by +$4.96 M (+53.38%)